Literature DB >> 24762262

Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.

Jarosław Paluszczak1, Dawid Hemmerling, Magdalena Kostrzewska-Poczekaj, Małgorzata Jarmuż-Szymczak, Reidar Grenman, Małgorzata Wierzbicka, Wanda Baer-Dubowska.   

Abstract

BACKGROUND: Aberrations in the function of the WNT signaling pathway have been recently implicated in the pathogenesis of head and neck cancer, and the hypermethylation of several WNT cascade inhibitors were shown to be useful in disease prognosis. However, the extent of deregulation of WNT pathway by DNA hypermethylation has not been studied in detail in laryngeal cancer so far. The aim of this study was to establish the frequency of methylation of WNT pathway negative regulators in laryngeal squamous cell carcinomas and evaluate its prognostic significance.
METHODS: Twenty-six laryngeal squamous cell carcinoma cell lines and samples obtained from twenty-eight primary laryngeal carcinoma patients were analyzed. The methylation status of DKK1, LKB1, PPP2R2B, RUNX3, SFRP1, SFRP2, and WIF-1 was assessed using the methylation-specific polymerase chain reaction.
RESULTS: Frequent hypermethylation of DKK1, PPP2R2B, SFRP1, SFRP2, and WIF-1 was detected, and a high methylation index was usually observed. Half of the cell lines analyzed and seventy percent of primary laryngeal carcinoma cases were characterized by the methylation of at least four genes. The hypermethylation of PPP2R2B or WIF-1 was associated with longer survival in laryngeal carcinoma cell lines. Moreover, the concurrent methylation of PPP2R2B and SFRP1 differentiated primary from recurrent laryngeal carcinoma cell lines.
CONCLUSIONS: Frequent hypermethylation of WNT pathway negative regulators is observed in laryngeal squamous cell carcinomas. The possible prognostic significance of the methylation of DKK1, PPP2R2B, and SFRP1 needs to be evaluated in further prospective studies.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  DNA methylation; WNT pathway; epimarker; laryngeal cancer

Mesh:

Substances:

Year:  2014        PMID: 24762262     DOI: 10.1111/jop.12178

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  13 in total

Review 1.  Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.

Authors:  Roya Tabatabai; Yuliya Linhares; David Bolos; Monica Mita; Alain Mita
Journal:  Target Oncol       Date:  2017-10       Impact factor: 4.864

2.  The translational significance of epithelial-mesenchymal transition in head and neck cancer.

Authors:  Christian A Graves; Fadi F Abboodi; Swati Tomar; James Wells; Lucia Pirisi
Journal:  Clin Transl Med       Date:  2014-11-30

3.  Diagnostic value of WIF1 methylation for colorectal cancer: a meta-analysis.

Authors:  Haochang Hu; Bin Li; Cong Zhou; Xiuru Ying; Min Chen; Tianyi Huang; Yuehong Chen; Huihui Ji; Ranran Pan; Tiangong Wang; Danjie Jiang; Yanfei Chen; Yong Yang; Shiwei Duan
Journal:  Oncotarget       Date:  2018-01-03

4.  Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.

Authors:  Jarosław Paluszczak; Dorota Wiśniewska; Magdalena Kostrzewska-Poczekaj; Katarzyna Kiwerska; Reidar Grénman; Daniela Mielcarek-Kuchta; Małgorzata Jarmuż-Szymczak
Journal:  Clin Oral Investig       Date:  2016-08-23       Impact factor: 3.573

Review 5.  Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review.

Authors:  Hao Guo; Shuni Zhou; Lili Tan; Xiaoyu Wu; Zhenfeng Wu; Ruizhi Ran
Journal:  Oncotarget       Date:  2017-01-10

6.  SFRP5 inhibits the migration and invasion of melanoma cells through Wnt signaling pathway.

Authors:  Yangmei Chen; Daopei Zou; Nan Wang; Tao Tan; Yu Liu; Qing Zhao; Yihuan Pu; Rabin Jung Thapa; Jin Chen
Journal:  Onco Targets Ther       Date:  2018-12-06       Impact factor: 4.147

7.  Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival.

Authors:  Aleksandra Majchrzak-Celińska; Marta Słocińska; Anna-Maria Barciszewska; Stanisław Nowak; Wanda Baer-Dubowska
Journal:  J Appl Genet       Date:  2015-09-04       Impact factor: 3.240

8.  CpG island methylation profile in non-invasive oral rinse samples is predictive of oral and pharyngeal carcinoma.

Authors:  Scott M Langevin; Melissa Eliot; Rondi A Butler; Agnes Cheong; Xiang Zhang; Michael D McClean; Devin C Koestler; Karl T Kelsey
Journal:  Clin Epigenetics       Date:  2015-12-03       Impact factor: 6.551

9.  Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.

Authors:  Piti Techavichit; Yang Gao; Lyazat Kurenbekova; Ryan Shuck; Lawrence A Donehower; Jason T Yustein
Journal:  BMC Cancer       Date:  2016-11-08       Impact factor: 4.430

Review 10.  Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer: A systematic meta-analysis.

Authors:  Yu Zheng; Xia Li; Yiming Jiang; Yufen Xu; Binbin Song; Qiang Zhou; Xiaodong Liang; Xinmei Yang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.